COX-2 inhibitors: a potential target for drug therapy in the management of colorectal cancer
Colorectal cancer is currently the third most common cancer in Malaysia. Elevated expression of COX-2, an induced cyclooxygenase isoenzyme, has been seen in colonic adenomas and colorectal carcinoma. There is evidence that inhibition of this COX-2 can decrease the risk of colorectal cancer. Selectiv...
Saved in:
Main Authors: | Ryan, A R, Rosita, A R, Khalid, Kamarul Ariffin, Qureshi, Akhtar |
---|---|
Format: | Article |
Language: | English |
Published: |
Malaysian Medical Association
1999
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/23984/1/COX-2_Inhibitors_-_A_Potential_Target_for_Drug_Therapy_in_the_Management_of_Colorectal_Cancer.pdf http://irep.iium.edu.my/23984/ http://www.e-mjm.org/index.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in targeted and immunobased therapies for colorectal cancer in the genomic era
by: Heng, Fong Seow, et al.
Published: (2016) -
RAS and BRAF genes as biomarkers and target for personalised colorectal cancer therapy: An update
by: Ooi, Zhuan Shern *, et al.
Published: (2022) -
Antibody-drug conjugates: the paradigm shifts in the targeted
cancer therapy
by: Aggarwal, Devesh, et al.
Published: (2023) -
Colorectal cancer stem cells: a review of targeted drug delivery by gold nanoparticles
by: Mohd Zahid, Manali Haniti, et al.
Published: (2020) -
Drug design and synthesis of cox-2 selective inhibitors as potential NSAIDs / Abeer Abdulhadi Abdulqader
by: Abeer Abdulhadi , Abdulqader
Published: (2016)